You are here

A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients

Last updated on March 11, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Kasuga, Fukuoka, Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Acute Coronary Syndrome
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Recent (≤ 7 days) ACS

- Clinically stable, and receiving standard treatment (patients must be treated with
aspirin ≤ 100 mg/day, with or without clopidogrel 75 mg/day or ticlopidine 200 mg/day)
based on the physician's judgment)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Scheduled/planned cardiac catheterization, PCI, CABG or other invasive procedure
planned in the 24 weeks (within treatment period) following randomization

- Persistent severe hypertension, defined as systolic blood pressure of ?180 mm Hg or
diastolic pressure of ?110 mm Hg

- Active bleeding or at high risk for bleeding (e.g., cirrhosis of the liver, any
history of intracranial hemorrhage).

NCT00852397
Pfizer
Terminated
A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Acute Coronary Syndrome
NCT00728988
All Genders
18+
Years
Multiple Sites
Acute Coronary Syndrome
NCT00852397
All Genders
20+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now